What Phase 1 Does
Phase 1 is not a diet app or a prescription tool. It is a safety-first engine that understands how
GLP-1 and similar medications are being used in real life and turns that into structured signals.
- Captures core facts: medication name, dose, schedule and route.
- Tracks weight trends and key metabolic context without giving diagnosis.
- Highlights simple, non-diagnostic safety patterns that may need attention.
- Prepares clean, auditable data for later phases such as Phase 4 and Phase 8.
Safety & Non-Diagnostic Boundaries
Phase 1 stays firmly on the wellness and safety side of the line. It does not replace
a doctor, clinic or hospital, and it never tells users to change their medication.
- No diagnosis, no prescriptions, no dose adjustments.
- Language tuned for “things to watch” and “questions to ask your clinician”.
- Simple traffic-light style signals that can feed into later clinical tools.
- Designed for NHS, EU, GCC and global SaMD boundary expectations.
Who Uses Phase 1 and How It Fits the 17-Phase Roadmap
Phase 1 is designed to be useful to normal families, clinicians and ministries from day one,
while also acting as the backbone for future phases of Elisence.
- Families and individuals log simple, structured information about medication and weight.
- Clinicians and clinics can review clear summaries instead of raw chat logs or screenshots.
- Ministries and hospitals can later plug this core into larger analytics engines.
The outputs of Phase 1 are designed to connect directly into:
Phase 3 (Care & Weight-Loss Journeys),
Phase 4 (Provenance & Integrity Engine),
Phase 8 (AHE & Clinical Profiles),
and Phase 9 (Diabetes & Metabolic Health).